LMR Partners’s OnKure Therapeutics OKUR Stock Holding History

LMR Partners’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,470	Closed	-$120K	–	1352
2023 Q4	$120K	Buy	+7,470	New	+$466K	﹤0.01%	754

Other funds holding OKUR

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

LMR Partners's OKUR Position: Q1 2024 in Review

LMR Partners sold out of OnKure Therapeutics (OKUR) in Q1 2024, closing a stake of 4,500 shares — an estimated $72K sold.

LMR Partners first reported a position in OKUR in Q4 2023 and held it in 1 quarter. The position peaked at $72K in Q4 2023. 61 funds tracked by Wall St. Rank hold OKUR as of Q1 2024.

LMR Partners reported no remaining OnKure Therapeutics position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 4,500 OnKure Therapeutics shares in Q1 2024, an estimated $72K.
LMR Partners first reported a position in OnKure Therapeutics in Q4 2023 and held it in 1 quarter.
LMR Partners's OnKure Therapeutics position peaked at $72K in Q4 2023.
61 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.